Posts by: Ana Pamplona, PhD

Ana Pamplona, PhD

Ana holds her PhD in Biochemistry from the Faculty of Science and Technology from Lisbon (UNL). She has worked in the T-cell differentiation and Tumor targeting Lab at Instituto de Medicina Molecular, headed by Prof. Bruno Silva-Santos, and has served as a scientific reviewer for the peer-reviewed journal Infection & Immunity.

February 26, 2015November 9, 2015

Inflammatory Protein Associated with COPD Severity

COPD, News

A recent study entitled “Evaluation of serum interleukin-1 beta as an inflammatory marker in COPD patients” was published in the Egyptian Journal of Chest Diseases and Tuberculosis by Dr. Dina ... Read more

February 11, 2015February 11, 2015

Physicians Overprescribe Antibiotics in Outpatient Respiratory Tract Infection Settings, Study Shows

Chronic Bronchitis, News

A recent report revealed that in ambulatory care or during outpatient visits, approximately 40% of all antibiotics prescribed for acute respiratory tract infections (RTIs) are not appropriate for these conditions. ... Read more

February 6, 2015November 5, 2015

iBioModulator Portfolio & Product Pipeline From Pulmonary Fibrosis, SSc Drug Developer iBio Gains Key Patent

Idiopathic Pulmonary Fibrosis, News

iBio, Inc recently announced that the company was approved for a new U.S. patent entitled “Yersinia pests Antigens, Vaccine Compositions and Related Methods.” The scope of this new patent includes plague antigens combined with the ... Read more

January 29, 2015November 5, 2015

Idiopathic Pulmonary Fibrosis Macrophage Activation in Acute Exacerbations Explored in New Study

Idiopathic Pulmonary Fibrosis, News

A new study on Acute Exacerbation of Idiopathic Pulmonary Fibrosis entitled “Macrophage Activation in Acute Exacerbation of Idiopathic Pulmonary Fibrosis” was published in PLOS One by Jonas Christian Schupp, part ... Read more

January 19, 2015January 19, 2015

Diagnosing Pulmonary Arterial Hypertension in Systemic Sclerosis Patients More Effective Using Novel Screening Algorithms

News

A new study on systemic sclerosis entitled “A comparison of the predictive accuracy of three screening models for pulmonary arterial hypertension in systemic sclerosis” was published in Arthritis Research & ... Read more

January 12, 2015November 6, 2015

Researchers Discover That Mycoplasma Pneumoniae CARDS Toxin Induces Inflammation in Lungs

Asthma, News

A recent study discovered a bacterial toxin that induces acute inflammation in asthma and other acute and chronic pulmonary diseases. The study entitled “ADP-Ribosylation of NLRP3 by Mycoplasma pneumoniae CARDS ... Read more

January 9, 2015November 11, 2015

Novartis Submits New Drug Applications For Two New COPD Therapies

COPD, News

Novartis submitted two New Drug Applications (NDAs) for QVA149 and NVA237 for the long-term maintenance treatment of chronic obstructive pulmonary disease (COPD) to the U.S. Food and Drug Administration (FDA). ... Read more

January 7, 2015January 7, 2015

HIV-positive Children at Higher risk of Pneumonia

Pneumonia

The first worldwide study on the negative impact of pneumonia in HIV-positive children entitled “Global, regional, and national estimates of pneumonia burden in HIV-infected children in 2010: a meta-analysis and ... Read more

December 29, 2014November 5, 2015

Quinsair Treatment For Pseudomonas Aeruginosa in Adult CF Patients Picks Up Positive CHMP Opinion

Cystic Fibrosis, News

The Committee for Medicinal Products for Human Use (CHMP) recently announced a positive comment for the pharmaceutical compound Quinsair, a nebuliser solution administered in a 240 mg dose, based on ... Read more

December 17, 2014November 5, 2015

Researchers Offer Insights Into Use of Right Heart Catheter Measurements, CMR Volumetrics in CTEPH

News, Pulmonary Hypertension

A new study on chronic thromboembolic pulmonary hypertension entitled “Right ventricular adaptation to pulmonary pressure load in patients with chronic thromboembolic pulmonary hypertension before and after successful pulmonary endarterectomy – ... Read more